Empowering Early Intervention: Navigating Treatments for Delaying T1D Progression, Insights from Pediatric Endocrinology of North Texas - Episode 9

Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process

, , ,

Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.

EP. 1: Navigating T1D: Mitigating Burden and Monitoring Disease Progression
EP. 2: T1D Staging: The Clinical Importance of Early Recognition
EP. 3: Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
EP. 4: T1D Antibody Screening: Identifying High-Risk Populations
EP. 5: Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression
EP. 6: TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data
EP. 7: Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
EP. 8: Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
Now Viewing
EP. 9: Expert Opinions into the Range of Teplizumab Infusion Locations, Insurance Coverage Hurdles, and the Approval Process
EP. 10: Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab